BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 12816990)

  • 1. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
    Link JM; Rich CM; Korat M; Burrows GG; Offner H; Vandenbark AA
    Clin Immunol; 2007 Apr; 123(1):95-104. PubMed ID: 17257899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
    Oliver AR; Lyon GM; Ruddle NH
    J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
    Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS
    J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
    Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y
    Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
    J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
    Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
    J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
    Lobell A; Weissert R; Eltayeb S; de Graaf KL; Wefer J; Storch MK; Lassmann H; Wigzell H; Olsson T
    J Immunol; 2003 Feb; 170(4):1806-13. PubMed ID: 12574345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
    Mendel I; Natarajan K; Ben-Nun A; Shevach EM
    J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive.
    Ito A; Matejuk A; Hopke C; Drought H; Dwyer J; Zamora A; Subramanian S; Vandenbark AA; Offner H
    J Immunol; 2003 May; 170(9):4802-9. PubMed ID: 12707362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
    Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
    Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.